And I saw Sisyphus in agonizing torment trying to roll a huge stone to the top of a hill. He would brace himself, and push it towards the summit with both hands, but just as he was about to heave it over the crest its weight overcame him, and then down again to the plain came bounding that pitiless boulder. He would wrestle again, and lever it back, while the sweat poured from his limbs, and the dust swirled round his head.
I
n 2012, the Centers for Medicare and Medicaid Services (CMMS) began penalizing hospitals on the basis of the number of all-cause hospital readmissions within 30 days following an index hospitalization for heart failure, acute myocardial infarction, and pneumonia (2) . In a given year, if a hospital's number of these events exceed the number expected, the hospital is penalized by a percentage of total Medicare revenue; that is, it is denied full payment for the services that it has provided to Medicare beneficiaries during that year. The maximum penalty has risen from an initial 1% to 3% of revenue. In understanding the construct of this metric, it is worth remembering its purpose: to save money for Medicare, a worthy goal, that is, to reduce the estimated $26 billion annual price tag associated with the 18% 30-day readmission rate across the country (3).
It is important, to both CMMS and providers, to predict the probability of readmission from available data related to a hospital's patient population or from individual patients. For CMMS, the prediction drives estimation of the expected readmission rate. Both CMMS and providers seek the best possible estimation in order for the metric to operate fairly. Prediction also allows providers to cost effectively allocate resources needed to prevent readmission. However, as pointed out by Krumholz et al. (4) in this issue of JACC: Heart Failure, existing models constructed both inside (5) and outside (6,7) CMMS have relatively poor discrimi- reported that they have no relationships relevant to the contents of this paper to disclose. Mortality, estimated in Medicare fee-for-service beneficiaries at 10.7% during the 30 days following heart failure discharge (11) , is a competing risk for hospitalization; that is, patients who die cannot be hospitalized, so perversely, an increased rate of death reduces the probability of rehospitalization. Heart failure clinical trials usually account for this issue by including both death and hospitalization in a composite endpoint. Being blind to death, the readmission metric is a utilization metric but should not be considered a quality metric. Treatments shown to reduce mortality have also reduced heart failure hospitalization (12) (13) (14) (15) (16) We know a lot about prognosis and treatment in heart failure, and use of that knowledge allows us to both predict and prevent post-discharge heart failure- E-mail: mkonstam@tuftsmedicalcenter.org.
